Medical Director Dermatology Institute and Skin Care Center Medical Director Clinical Science Institute Clinical Assistant Professor David Geffen School of Medicine at UCLA Adjunct Associate Professor John Wayne Cancer Center
Dermatology
Dr. Paul S. Yamauchi, MD
|
|
Give Review
Paul S. Yamauchi, MD works in the field of Dermatology. He attended Case Western Reserve University School of Medicine. He over the years received 6 awards: "Marquis Who's Who in America", "Marquis Who's Who in Medicine and Healthcare", "America's Top Doctors", "Fellow (FASDS)", "Fellow (FAAD)" and "Super Doctor". Dr. Paul S. Yamauchi is also a published MD. He has 51 paper published. The most recent paper is: Absence of 2'-deoxy-GTP in adult brain tubulin. Dr. Paul S. Yamauchi is registered with Medicare.
Publications
- Combining Biologic Therapies With Other Systemic Treatments in Psoriasis: Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasi...
- OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of Psoriasis final 5-year results.
- OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of Psoriasis.
- Adalimumab treats Psoriasis in patients previously treated with etanercept: a case series.
- Rapidly growing squamous Cell carcinoma from permanent makeup tattoo.
- Hidradenitis suppurativa managed with adalimumab.
- Nonsurgical management of hyperhidrosis.
- Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe Psoriasis.
- Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures.
- Current and emerging therapeutic modalities for hyperhidrosis, part 1: conservative and noninvasive treatments.
- A treatment strategy for Psoriasis: transitioning from systemic therapy to biologic agents.
- Adapalene gel, 0.1%, as maintenance therapy for Acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.
- Treatment of coexisting bullous pemphigoid and Psoriasis with the tumor necrosis factor antagonist etanercept.
- Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept.
- Cessation of cyclosporine therapy by treatment with etanercept in patients with severe Psoriasis.
- The treatment of Psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
- Retinoid therapy for Psoriasis.
- Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
- Laser and novel light source treatments for Psoriasis.
- Current systemic therapies for Psoriasis: where are we now?
- Photodynamic therapy with topical methyl aminolevulinate for Actinic keratosis: results of a prospective randomized multicenter trial.
- Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study.
- Idiopathic CD4+T-Cell lymphocytopenia associated with vitiligo.
- Emerging permanent filler technologies: focus on Aquamid.
- Reduction in microtubule dynamics in vitro by brain microtubule-associated proteins and by a microtubule-associated protein-2 second repeated sequence analogue.
- Modulation of microtubule assembly and stability by phosphatidylinositol action on microtubule-associated protein-2.
- Microtubule-associated protein autophosphorylation alters in vitro microtubule dynamic instability.
- Treatment of port wine stains using the pulsed-dye laser at 585 nm with the dynamic cooling device.
- Treatment of pseudofolliculitis barbae with the diode laser.
- A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
- Absence of 2'-deoxy-GTP in adult brain tubulin.
- Microtubule-associated protein interactions with actin filaments: evidence for differential behavior of neuronal MAP-2 and tau in the presence of phosphatidyl-inositol.
- Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.
- Topical photodynamic therapy in clinical dermatology.
- Soft tissue filler and botulinum toxin treatment techniques.
- Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with...
- Etanercept for severe Psoriasis and psoriatic arthritis: observations on combination therapy.
- Effects of etanercept on C-reactive protein levels in Psoriasis and psoriatic arthritis.
- The function of a ribosomal frameshifting signal from human immunodeficiency virus-1 in Escherichia coli.
- Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
- Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
- Can patients treat themselves with a small novel light based hair removal system?
- Cosmetic uses of botulinum toxins for lower aspects of the face and neck.
- Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial Skin: a multicenter, double-blind, randomized, parallel-group study.
- An assessment of traditional and novel therapies for Cellulite.
- Combination therapy with adapalene gel 0.1% and doxycycline for severe Acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.
- Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing.
- A review of lasers and light sources in the treatment of Acne vulgaris.
- Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations.
- Perioperative use of anti-tumor necrosis factor-alfa agents.
Schools
Case Western Reserve University School of Medicine
University Rochester
UCLA
Procedures Preformed
- Acne Surgery
- Adjacent Tissue Transfer
- Destruction of Benign Skin Lesion
- Mohs Surgery
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Marquis Who's Who in America
- Marquis Who's Who in Medicine and Healthcare
- America's Top Doctors
- Fellow (FASDS)
- Fellow (FAAD)
- Super Doctor
Education
-
UCLA Medical Center -
University of Rochester -
Case Western Reserve University School of Medicine
Hospital
-
Santa Monica-UCLA Medical Center and Orthopaedic Hospital -
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1720074537 | |
| NPPES Provider LastName | YAMAUCHI | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 904042102 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 617.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720074537 |
| Last Name Of The Provider | YAMAUCHI |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Jonathan A. Cotliar, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ava T. Shamban, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elisabeth K. Shim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Billie M. Phelps, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger S. Lo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tanya Kormeili, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley Alfred, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vanessa R. Holland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karyn L. Grossman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adriana N. Schmidt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor M. Schultz, MD |
|
|
Dr. Sarah N. Gee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald J. Hale, MD
This Doctor is OpenDoctor Recommended.
|